Percent change in outcomes from the presence of pipeline drugs by age, viral load, and CD4 count at initiation of therapy.

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA functional class I, in those supplemented with selenium and coenzyme Q10 versus placebo during four years on top of regular pharmaceutic treatment during a follow-up period of 10 years.

Urban Alehagen (796660)
Jan Aaseth (796661)
Peter Johansson (64440)

December 2015

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA function...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a f...

Calculation of changes in life expectancy based on proportional hazards model of an intervention

Kulinskaya, Elena
Bakbergenuly, Ilyas
Gitsels, Lisanne
Wright, Nigel

July 2020

Mortality projections are of great interest to the pension and insurance industry and with an ageing...

Sensitivity analysis of effect percent change in LE and QALE from the presence of pipeline drugs by age, viral load, and toxicity.

Amin Khademi (458359)
R. Scott Braithwaite (253100)
Denis Saure (588494)
Andrew J. Schaefer (49948)
Kimberly Nucifora (253102)
Mark S. Roberts (178430)

June 2014

The graphs on the left depict the percent change in life expectancy assuming new drugs have a low...

Path Graph for Proportion of Treatment Effect for Overall Mortality.

Justin M. Belcher (785966)
Steven G. Coca (451682)
Chirag R. Parikh (451681)

August 2015

Figure represents the path graph used to calculate the proportion of treatment effect (PTE) for o...

Graphs showing the secular trend of annual crude mortality rates of cerebrovascular diseases in selected studies included objects of all ages, for both (panel A) and men or women (panel B or C).

Xiaomei Wu (16641)
Bo Zhu (118038)
Lingyu Fu (476914)
Hailong Wang (21678)
Bo Zhou (15092)
Safeng Zou (481473)
Jingpu Shi (409022)

November 2013

Graphs showing the secular trend of annual crude mortality rates of cerebrovascular diseases in s...

A graph showing the death trends among persons on treatment co-infected with DR-TB/HIV in Mulago National Referral Hospital.

Joan Rokani Bayowa (16503026)
Joan N. Kalyango (8605191)
Joseph Baruch Baluku (8863331)
Richard Katuramu (324177)
Emmanuel Ssendikwanawa (16503029)
Jane Frances Zalwango (14040926)
Rebecca Akunzirwe (14040923)
Stella Maris Nanyonga (16503032)
Judith Ssemasazi Amutuhaire (16503035)
Ronald Kivumbi Muganga (16503038)
Adolphus Cherop (16503041)

July 2023

A graph showing the death trends among persons on treatment co-infected with DR-TB/HIV in Mulago Nat...

Correlation Between Change in Serum Creatinine During Treatment and Relative Risk of Overall Mortality.

Justin M. Belcher (785966)
Steven G. Coca (451682)
Chirag R. Parikh (451681)

August 2015

Bubbles graphs depict the correlation between changes in creatinine while on treatment with overa...

Kaplan-Meier graph showing cumulative mortality after initiation of antiretroviral treatment according to co-infection with hepatitis B virus (upper graph) and hepatitis C virus (lower graph).

Johan van Griensven (333866)
Lay Phirum (522581)
Kimcheng Choun (333862)
Sopheak Thai (333860)
Anja De Weggheleire (144112)
Lutgarde Lynen (300843)

February 2014

Kaplan-Meier graph showing cumulative mortality after initiation of antiretroviral treatment acco...

Kaplan-Meier graph illustrating cardiovascular mortality during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality during a follow-up period of 12 years of...

Life expectancy gains apportioned to different causes of death in Ethiopia from 1990 to 2015.

Gizachew Balew Jembere (5814869)
Youngtae Cho (3120189)
Myunggu Jung (5814872)

October 2018

This graph shows the average life expectancy that is attributed by either reduction or shift in mort...

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in those supplemented with selenium and coenzyme Q10 versus placebo during four years on top of regular pharmaceutic treatment during a follow-up period of 10 years.

Urban Alehagen (796660)
Jan Aaseth (796661)
Peter Johansson (64440)

December 2015

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in those supplem...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with hypertension during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with hypertension during...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with ischemic heart disease during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with ischemic heart dise...

Age-dependent changes in the proportion of patients with significant concentrations of sIgG4.

Sergei Voloshin (4994330)
Olga Smoldovskaya (4994339)
Guzel Feyzkhanova (4994336)
Alla Arefieva (4994333)
Lyudmila Pavlushkina (4994327)
Tatiana Filatova (4994324)
Veronika Butvilovskaya (4994318)
Marina Filippova (4994348)
Yuri Lysov (4994342)
Sergey Shcherbo (4994345)
Alexander Makarov (1319898)
Alla Rubina (4994321)
Alexander Zasedatelev (4994351)

March 2018

Age-dependent changes in the proportion of patients with significant concentrations of sIgG4.</p

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA functional class I, in those supplemented with selenium and coenzyme Q10 versus placebo during four years on top of regular pharmaceutic treatment during a follow-up period of 10 years.

Urban Alehagen (796660)
Jan Aaseth (796661)
Peter Johansson (64440)

December 2015

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA function...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a f...

Calculation of changes in life expectancy based on proportional hazards model of an intervention

Kulinskaya, Elena
Bakbergenuly, Ilyas
Gitsels, Lisanne
Wright, Nigel

July 2020

Mortality projections are of great interest to the pension and insurance industry and with an ageing...

Sensitivity analysis of effect percent change in LE and QALE from the presence of pipeline drugs by age, viral load, and toxicity.

Amin Khademi (458359)
R. Scott Braithwaite (253100)
Denis Saure (588494)
Andrew J. Schaefer (49948)
Kimberly Nucifora (253102)
Mark S. Roberts (178430)

June 2014

The graphs on the left depict the percent change in life expectancy assuming new drugs have a low...

Path Graph for Proportion of Treatment Effect for Overall Mortality.

Justin M. Belcher (785966)
Steven G. Coca (451682)
Chirag R. Parikh (451681)

August 2015

Figure represents the path graph used to calculate the proportion of treatment effect (PTE) for o...

Graphs showing the secular trend of annual crude mortality rates of cerebrovascular diseases in selected studies included objects of all ages, for both (panel A) and men or women (panel B or C).

Xiaomei Wu (16641)
Bo Zhu (118038)
Lingyu Fu (476914)
Hailong Wang (21678)
Bo Zhou (15092)
Safeng Zou (481473)
Jingpu Shi (409022)

November 2013

Graphs showing the secular trend of annual crude mortality rates of cerebrovascular diseases in s...

A graph showing the death trends among persons on treatment co-infected with DR-TB/HIV in Mulago National Referral Hospital.

Joan Rokani Bayowa (16503026)
Joan N. Kalyango (8605191)
Joseph Baruch Baluku (8863331)
Richard Katuramu (324177)
Emmanuel Ssendikwanawa (16503029)
Jane Frances Zalwango (14040926)
Rebecca Akunzirwe (14040923)
Stella Maris Nanyonga (16503032)
Judith Ssemasazi Amutuhaire (16503035)
Ronald Kivumbi Muganga (16503038)
Adolphus Cherop (16503041)

July 2023

A graph showing the death trends among persons on treatment co-infected with DR-TB/HIV in Mulago Nat...

Correlation Between Change in Serum Creatinine During Treatment and Relative Risk of Overall Mortality.

Justin M. Belcher (785966)
Steven G. Coca (451682)
Chirag R. Parikh (451681)

August 2015

Bubbles graphs depict the correlation between changes in creatinine while on treatment with overa...

Kaplan-Meier graph showing cumulative mortality after initiation of antiretroviral treatment according to co-infection with hepatitis B virus (upper graph) and hepatitis C virus (lower graph).

Johan van Griensven (333866)
Lay Phirum (522581)
Kimcheng Choun (333862)
Sopheak Thai (333860)
Anja De Weggheleire (144112)
Lutgarde Lynen (300843)

February 2014

Kaplan-Meier graph showing cumulative mortality after initiation of antiretroviral treatment acco...

Kaplan-Meier graph illustrating cardiovascular mortality during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality during a follow-up period of 12 years of...

Life expectancy gains apportioned to different causes of death in Ethiopia from 1990 to 2015.

Gizachew Balew Jembere (5814869)
Youngtae Cho (3120189)
Myunggu Jung (5814872)

October 2018

This graph shows the average life expectancy that is attributed by either reduction or shift in mort...

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in those supplemented with selenium and coenzyme Q10 versus placebo during four years on top of regular pharmaceutic treatment during a follow-up period of 10 years.

Urban Alehagen (796660)
Jan Aaseth (796661)
Peter Johansson (64440)

December 2015

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in those supplem...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with hypertension during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with hypertension during...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with ischemic heart disease during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with ischemic heart dise...

Age-dependent changes in the proportion of patients with significant concentrations of sIgG4.

Sergei Voloshin (4994330)
Olga Smoldovskaya (4994339)
Guzel Feyzkhanova (4994336)
Alla Arefieva (4994333)
Lyudmila Pavlushkina (4994327)
Tatiana Filatova (4994324)
Veronika Butvilovskaya (4994318)
Marina Filippova (4994348)
Yuri Lysov (4994342)
Sergey Shcherbo (4994345)
Alexander Makarov (1319898)
Alla Rubina (4994321)
Alexander Zasedatelev (4994351)

March 2018

Age-dependent changes in the proportion of patients with significant concentrations of sIgG4.</p

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA functional class I, in those supplemented with selenium and coenzyme Q10 versus placebo during four years on top of regular pharmaceutic treatment during a follow-up period of 10 years.

Urban Alehagen (796660)
Jan Aaseth (796661)
Peter Johansson (64440)

December 2015

Kaplan-Meier graph illustrating cardiovascular mortality in the study population in NYHA function...

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a follow-up period of 12 years of those supplemented with selenium and coenzyme Q10 versus placebo for four years on top of regular pharmaceutical treatment.

Urban Alehagen (796660)
Jan Aaseth (796661)
Jan Alexander (78599)
Peter Johansson (64440)

April 2018

Kaplan-Meier graph illustrating cardiovascular mortality in participants with diabetes during a f...

Calculation of changes in life expectancy based on proportional hazards model of an intervention

Kulinskaya, Elena
Bakbergenuly, Ilyas
Gitsels, Lisanne
Wright, Nigel

July 2020

Mortality projections are of great interest to the pension and insurance industry and with an ageing...

Percent change in outcomes from the presence of pipeline drugs by age, viral load, and CD4 count at initiation of therapy.

Abstract

Extracted data

Percent change in outcomes from the presence of pipeline drugs by age, viral load, and CD4 count at initiation of therapy.

Abstract

Extracted data

Related items

Related items